Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Capricor Therapeutics Inc

NLTX:US

Ticker Change

Company Profile for Capricor Therapeutics Inc (NLTX)

Capricor Therapeutics, Inc. is a clinical stage biotechnology company focused on the development and commercialization of regenerative medicine and large molecule products for the prevention and treatment of heart failure and heart attacks.

Contact Information

Capricor Therapeutics Inc

8840 Wilshire Blvd
2nd floor
Beverly Hills, CA 90211
United States
Phone: 1-310-358-3200
Fax: 1-310-358-3209

Key Executives for Capricor Therapeutics Inc (NLTX)

Frank LitvackChairmanLinda MarbanPresident/CEO/Co-Founder
Karen G KrasneyExec VP/General CounselAnthony J BergmannVP:Finance
Andrew HamerVP:Medical AffairsRachel SmithVP:Research & Development

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil